Ovidrel® PreFilled Syringe (choriogonadotropin alfa injection)

Important Safety Information

Ovidrel® PreFilled Syringe is a potent gonadotropic substance capable of causing Ovarian Hyperstimulation Syndrome (OHSS) and ovarian enlargement with or without pulmonary and vascular complications.

Adverse reactions reported include injection site reactions, GI disorders, abdominal pain, nausea, vomiting, ovarian cyst, ovarian hyperstimulation, and thromboembolic events. Multiple births and congenital abnormalities have been reported.

For complete information, please see full Prescribing information.

Ovidrel® is a registered trademark of Merck KGaA, Darmstadt, Germany or its affiliates.

Action SVG
Action SVG
Action SVG
eMedI Chat
After your vist, Please answer a few questions to help us improve?
Please click on icon to provide survey...